Chemomab Therapeutics market cap CMMB
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 2, 2026
- $678.9M
- Highest close in our data
- $1.6B
- Aug 2026
Chemomab Therapeutics is worth $678.9M at the close on Nov 2, 2026, at $1.18 a share.
That is up 173% over the last year and up 510% over five years.
Its highest close in our data was $1.6B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $678.9M | $142.4M | $1.6B | +300% |
| 2025 | $169.7M | $169.7M | $608M | −70% |
| 2024 | $571M | $5.5M | $573.9M | +10033% |
| 2023 | $5.6M | $5.2M | $358M | −85% |
| 2022 | $36.9M | $22.9M | $1.1B | −53% |
| 2021 | $78.7M | $46M | $887.4M | +23% |
| 2020 | $64.2M | $13.2M | $88.3M | +190% |
| 2019 | $22.1M | $21.3M | $91.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Chemomab Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| CMMBChemomab Therapeutics | $678.9M |
| ZVRAZevra Therapeutics | $599.8M |
| COLLCollegium Pharmaceutical | $770.9M |
| ABUSArbutus Biopharma | $791.4M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PBYIPuma Biotechnology | $525.5M |
| ARVNArvinas | $491.7M |
| CRMDCorMedix | $420.1M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.3B |
| ANABAnaptysbio | $1.4B |
| Peer median | $685.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Chemomab Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.